New combo aims to shield diabetic bones from breaking
NCT ID NCT07063797
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding denosumab to standard care can strengthen bones and prevent fractures in 358 adults with type 2 diabetes who are at high risk for breaks. Participants will receive the drug or a placebo, and researchers will measure changes in bone density and fracture rates over time. The goal is to find a better way to manage osteoporosis in diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRACTURES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huai'an First People's Hospital
Huai'an, China
-
Jiangxi Provincial People's Hospital
Jiangxi, China
-
Kunshan Hospital of Traditional Chinese Medicine
Kunshan, China
-
Peking Union Medical College Hospital
Beijing, Dongcheng, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Can discarded bone reveal the secrets to stronger bones?
- Could a common diabetes drug weaken your bones?
- A tastier calcium chew might boost bone Health—But does it work?
- Blood test could predict who faces rapid kidney decline in diabetes
- Exercise program aims to steady the stance of osteoporosis patients